丝裂霉素、阿霉素和顺铂联合用于晚期肉瘤的II期研究
Phase II study of a combination of mitomycin, doxorubicin and cisplatin in advanced sarcomas.
作者信息
Edmonson J H, Long H J, Richardson R L, Creagan E T, Green S J
出版信息
Cancer Chemother Pharmacol. 1985;15(2):181-2. doi: 10.1007/BF00257535.
PMID:2990751
Abstract
In all 63 patients were treated monthly with a combination of mitomycin, doxorubicin, and cisplatin, and 27 (43%) experienced objective regression of their advanced sarcomas during a 3-month trial. The observed regression rate is numerically higher than any previously observed at our institution.
摘要
63名患者均每月接受丝裂霉素、阿霉素和顺铂联合治疗，在为期3个月的试验中，27名（43%）患者的晚期肉瘤出现了客观缓解。观察到的缓解率在数值上高于我们机构之前观察到的任何缓解率。
Zotero 插件